India has begun the process of legislating a new law on the treatment of anaplastic anemia.

The law, called the Antisepsis Definition, aims to reduce the incidence of the condition and will be brought in for promulgation by the next biennial biennial session of Parliament.

It has been hailed as an “important step towards making the anaplasia treatment available to all Indians”.

It has also been welcomed by the government, who has taken up the issue with other countries, such as the US, the Netherlands and the UK.

“There are many more countries where people with anaplasmosis can be treated than India,” Health Minister Anil Baijal told reporters.

“So we will be looking at the US as well to see how we can work with them to make sure that they can implement this.

We will also look at other countries to see what can be done.”

The government is also considering the creation of an organisation for the prevention and management of the disease.

The definition will also have to be approved by the Cabinet, which will also decide on whether to go ahead with the legislation.

The legislation will come into force from January 1, 2018, and it will be valid for five years.

India is the second country to pass a law in the last few years that specifically deals with anaesthesia.

The first law, which came into force in January, required anaesthetists to give a medical certificate to a patient who has been referred to them for an anesthetic.

A medical certificate is required for the treatment and the patient must be referred to an anaestheist, who is supposed to sign off on the certificate.

The second law in March also came into effect, requiring that the anaesthetics used by anaesthat are administered by an anaesthetic surgeon, have to have an anesthesia certificate.

The law has not yet been ratified by the Parliament.

Last week, the Supreme Court upheld the legality of the anaesthesia act.